332 related articles for article (PubMed ID: 34440623)
1. Understanding Cervical Cancer through Proteomics.
Martínez-Rodríguez F; Limones-González JE; Mendoza-Almanza B; Esparza-Ibarra EL; Gallegos-Flores PI; Ayala-Luján JL; Godina-González S; Salinas E; Mendoza-Almanza G
Cells; 2021 Jul; 10(8):. PubMed ID: 34440623
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA Biomarkers of High-Grade Cervical Intraepithelial Neoplasia in Liquid Biopsy.
Causin RL; da Silva LS; Evangelista AF; Leal LF; Souza KCB; Pessôa-Pereira D; Matsushita GM; Reis RM; Fregnani JHTG; Marques MMC
Biomed Res Int; 2021; 2021():6650966. PubMed ID: 33954190
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylation of Single CpG Dinucleotides at the Promoter of CXCL13 Gene Promoting Cell Migration in Cervical Cancer.
Ma D; Fan SB; Hua N; Li GH; Chang Q; Liu X
Curr Cancer Drug Targets; 2020; 20(5):355-363. PubMed ID: 31899677
[TBL] [Abstract][Full Text] [Related]
4. Markers of Angiogenesis, Lymphangiogenesis, and Epithelial-Mesenchymal Transition (Plasticity) in CIN and Early Invasive Carcinoma of the Cervix: Exploring Putative Molecular Mechanisms Involved in Early Tumor Invasion.
Kurmyshkina O; Kovchur P; Schegoleva L; Volkova T
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899940
[TBL] [Abstract][Full Text] [Related]
5. Association study of relationships of polymorphisms in the miR-21, miR-26b, miR-221/222 and miR-126 genes with cervical intraepithelial neoplasia and cervical cancer.
Yang J; Yan Z; Wang Y; Xu J; Li R; Li C; Liu S; Shi L; Yao Y
BMC Cancer; 2021 Sep; 21(1):997. PubMed ID: 34488676
[TBL] [Abstract][Full Text] [Related]
6. DUSP7 inhibits cervical cancer progression by inactivating the RAS pathway.
Bai H; Song M; Jiao R; Li W; Zhao J; Xiao M; Jin M; Zhang Z; Deng H
J Cell Mol Med; 2021 Oct; 25(19):9306-9318. PubMed ID: 34435746
[TBL] [Abstract][Full Text] [Related]
7. A systematic study on dysregulated microRNAs in cervical cancer development.
He Y; Lin J; Ding Y; Liu G; Luo Y; Huang M; Xu C; Kim TK; Etheridge A; Lin M; Kong D; Wang K
Int J Cancer; 2016 Mar; 138(6):1312-27. PubMed ID: 26032913
[TBL] [Abstract][Full Text] [Related]
8. TOP2A and CENPF are synergistic master regulators activated in cervical cancer.
Yu B; Chen L; Zhang W; Li Y; Zhang Y; Gao Y; Teng X; Zou L; Wang Q; Jia H; Liu X; Zheng H; Hou P; Yu H; Sun Y; Zhang Z; Zhang P; Zhang L
BMC Med Genomics; 2020 Oct; 13(1):145. PubMed ID: 33023625
[TBL] [Abstract][Full Text] [Related]
9. Differentially expressed proteins among normal cervix, cervical intraepithelial neoplasia and cervical squamous cell carcinoma.
Zhao Q; He Y; Wang XL; Zhang YX; Wu YM
Clin Transl Oncol; 2015 Aug; 17(8):620-31. PubMed ID: 25893434
[TBL] [Abstract][Full Text] [Related]
10. Synaptonemal complex protein 3 is a prognostic marker in cervical cancer.
Cho H; Noh KH; Chung JY; Takikita M; Chung EJ; Kim BW; Hewitt SM; Kim TW; Kim JH
PLoS One; 2014; 9(6):e98712. PubMed ID: 24905095
[TBL] [Abstract][Full Text] [Related]
11. The role of EP3-receptor expression in cervical dysplasia.
Hester A; Ritzer M; Kuhn C; Schmoeckel E; Mayr D; Kolben T; Dannecker C; Mahner S; Jeschke U; Kolben TM
J Cancer Res Clin Oncol; 2019 Feb; 145(2):313-319. PubMed ID: 30402741
[TBL] [Abstract][Full Text] [Related]
12. Expression level of miRNA-210-3p in cervical cancer and its prognostic potential.
Shao MX; Qu AZ; Wang YQ; Zhong YY
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6583-6588. PubMed ID: 32633346
[TBL] [Abstract][Full Text] [Related]
13. Potential predictive plasma biomarkers for cervical cancer by 2D-DIGE proteomics and Ingenuity Pathway Analysis.
Guo X; Hao Y; Kamilijiang M; Hasimu A; Yuan J; Wu G; Reyimu H; Kadeer N; Abudula A
Tumour Biol; 2015 Mar; 36(3):1711-20. PubMed ID: 25427637
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
Wu B; Xi S
BMC Cancer; 2021 Aug; 21(1):928. PubMed ID: 34404366
[TBL] [Abstract][Full Text] [Related]
15. IMP3, a new biomarker to predict progression of cervical intraepithelial neoplasia into invasive cancer.
Lu D; Yang X; Jiang NY; Woda BA; Liu Q; Dresser K; Mercurio AM; Rock KL; Jiang Z
Am J Surg Pathol; 2011 Nov; 35(11):1638-45. PubMed ID: 21997684
[TBL] [Abstract][Full Text] [Related]
16. Expression profiles of metallothionein-I/II and megalin/LRP-2 in uterine cervical squamous lesions.
Jakovac H; Stašić N; Krašević M; Jonjić N; Radošević-Stašić B
Virchows Arch; 2021 Apr; 478(4):735-746. PubMed ID: 33084977
[TBL] [Abstract][Full Text] [Related]
17. Deregulated expression of superoxide dismutase-2 correlates with different stages of cervical neoplasia.
Termini L; Filho AL; Maciag PC; Etlinger D; Alves VA; Nonogaki S; Soares FA; Villa LL
Dis Markers; 2011; 30(6):275-81. PubMed ID: 21725155
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA expression in cervical cancer: Novel diagnostic and prognostic biomarkers.
Gao C; Zhou C; Zhuang J; Liu L; Liu C; Li H; Liu G; Wei J; Sun C
J Cell Biochem; 2018 Aug; 119(8):7080-7090. PubMed ID: 29737570
[TBL] [Abstract][Full Text] [Related]
19. Proteomics Analysis of Andrographolide-Induced Apoptosis via the Regulation of Tumor Suppressor p53 Proteolysis in Cervical Cancer-Derived Human Papillomavirus 16-Positive Cell Lines.
Udomwan P; Pientong C; Tongchai P; Burassakarn A; Sunthamala N; Roytrakul S; Suebsasana S; Ekalaksananan T
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202736
[TBL] [Abstract][Full Text] [Related]
20. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
